News
HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
NEO100 has been granted both Orphan Drug Designation and Fast Track Status by the U.S. Food and Drug Administration (FDA), reinforcing its potential as a significant advancement in the treatment of ...
2hOpinion
The Forward on MSNI operate a small Judaica business. Trump’s tariffs are going to squelch Jewish innovation.Raising the cost of manufacturing is going to make creators more cautious, writes the operator of a boutique Jewish press.
This is the second restaurant closing at the mall this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results